Le‐Xing Yu
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- Immunology 11
- Immune cells in cancer 5
- Immune Response and Inflammation 5
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- interferon and immune responses 2
- Co-authors
- Robert F. Schwabe (3 shared papers)Hongyang Wang (20 shared papers)Silvia Affò (2 shared papers)Wen Yang (8 shared papers)Mengchao Wu (8 shared papers)Ling Yan (3 shared papers)Liang Tang (5 shared papers)Linna Guo (5 shared papers)
- Journals
- Hepatology (4 papers)Nature Communications (2 papers)Journal of Hepatology (2 papers)Cell Death and Disease (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Le‐Xing Yu
26 papers receiving 3.9k citations
Le‐Xing Yu's Hit Papers
Peers
Comparison fields: 5 of 109
- Hepatology 640
- Cancer Research 1.0k
- Oncology 954
- Immunology 630
- Molecular Biology 2.0k
Countries citing papers authored by Le‐Xing Yu
This map shows the geographic impact of Le‐Xing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le‐Xing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le‐Xing Yu more than expected).
Fields of papers citing papers by Le‐Xing Yu
This network shows the impact of papers produced by Le‐Xing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le‐Xing Yu. The network helps show where Le‐Xing Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Le‐Xing Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer Hit paper breakdown → | 2018 | 790 |
| 2 | The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer Hit paper breakdown → | 2016 | 541 |
| 3 | The gut microbiome and liver cancer: mechanisms and clinical translation Hit paper breakdown → | 2017 | 437 |
| 4 | 2008 | 307 | |
| 5 | 2010 | 278 | |
| 6 | 2018 | 239 | |
| 7 | 2016 | 187 | |
| 8 | 2013 | 184 | |
| 9 | 2014 | 150 | |
| 10 | 2011 | 123 | |
| 11 | 2007 | 114 | |
| 12 | 2012 | 106 | |
| 13 | 2017 | 67 | |
| 14 | 2021 | 65 | |
| 15 | 2014 | 55 | |
| 16 | 2009 | 49 | |
| 17 | 2015 | 43 | |
| 18 | 2008 | 38 | |
| 19 | 2021 | 36 | |
| 20 | 2012 | 34 |
About Le‐Xing Yu
Le‐Xing Yu is a scholar working on Molecular Biology, Immunology, Oncology, Epidemiology and Hepatology, having authored 27 papers that have together received 3.9k indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Immune Response and Inflammation (5 papers), Liver physiology and pathology (4 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Hepatology (640 citations), Cancer Research (1.0k citations), Oncology (954 citations), Immunology (630 citations) and Molecular Biology (2.0k citations). Le‐Xing Yu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Robert F. Schwabe, Hongyang Wang, Silvia Affò, Wen Yang, Mengchao Wu, Ling Yan, Liang Tang, Linna Guo, He‐Xin Yan and Dan Cao. Their work appears in journals such as Hepatology, Nature Communications, Journal of Hepatology, Cell Death and Disease and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.